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M A J O R A R T I C L E
The Source of Respiratory Syncytial Virus
Infection In Infants: A Household Cohort Study
In Rural Kenya
Patrick K. Munywoki,1 Dorothy C. Koech,1 Charles N. Agoti,1 Clement Lewa,1 Patricia A. Cane,2 Graham F. Medley,2
and D. J. Nokes1,2
1KEMRI–Wellcome Trust Research Programme, Kiliﬁ, Kenya and 2School of Life Sciences and WIDER, University of Warwick, Coventry, United Kingdom
(See the editorial commentary by Graham on pages 1679–81.)
Background. Respiratory syncytial virus (RSV) vaccine development for direct protection of young infants faces
substantial obstacles. Assessing the potential of indirect protection using different strategies, such as targeting older
children or mothers, requires knowledge of the source of infection to the infants.
Methods. We undertook a prospective study in rural Kenya. Households with a child born after the preceding
RSV epidemic and ≥1 elder sibling were recruited. Nasopharyngeal swab samples were collected every 3–4 days irre-
spective of symptoms from all household members throughout the RSV season of 2009–2010 and tested for RSV
using molecular techniques.
Results. From 451 participants in 44 households a total of 15 396 nasopharyngeal swab samples were samples
were collected, representing 86% of planned sampling. RSV was detected in 37 households (84%) and 173 participants
(38%) and 28 study infants (64%). The infants acquired infection from within (15 infants; 54%) or outside (9 infants;
32%) the household; in 4 households the source of infant infection was inconclusive. Older children were index case
patients for 11 (73%) of the within-household infant infections, and 10 of these 11 children were attending school.
Conclusion. We demonstrate that school-going siblings frequently introduce RSV into households, leading to in-
fection in infants.
Keywords. RSV; infants; siblings; transmission; households.
Human respiratory syncytial virus (RSV) is a major
cause of childhood acute lower respiratory tract infection
worldwide [1]. The virus causes seasonal epidemics [2],
and approximately 60% of newborn are infected during
their ﬁrst year of life [3]. Concomitantly, the risk of
severe RSV associated respiratory disease after infection
is highest in early infancy, declining rapidly with increas-
ing age beyond 6 months [4], probably because of
physiological maturation of the airways [5]. Vaccine de-
velopment, in particular for live attenuated virus vac-
cines, has primarily targeted infants aged <3 months,
but no human RSV vaccine has been licensed as yet.
There are considerable obstacles confronting the devel-
opment of vaccines targeting young infants, including
immaturity of the immune system and presence of ma-
ternal RSV-speciﬁc antibodies–both of which are associ-
ated with suboptimal vaccine responses, and the balance
between immunogenicity and the risk of upper respira-
tory tract congestion associated with live vaccines [6].
Alternative strategies for RSV vaccination have
therefore been proposed [7], including delaying deliv-
ery to an older age [8], for which there is empirical
support. Live attenuated vaccines have been found safe
and immunogenic in seronegative children aged ≥6
months of age [6, 9, 10], subunit RSV vaccines boost
protective antibodies in previously infected individuals
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[11–14], and 40%–60% of RSV-associated community disease
that is severe and leads to hospitalization occur in children
aged ≥6 months [15–17].
In addition to direct protection of the recipient, vaccination
of older age groups may lead to indirect protection of the vul-
nerable infant by reducing circulation of virus in the population
or preventing chains of transmission to the infant [7]. This po-
tential beneﬁt requires knowledge of the source of infection for
infants. We conducted a household-based longitudinal study to
ascertain from whom infants derive their infection.
METHODS
Study Area
The study was undertaken in rural coastal Kenya within the
Kiliﬁ Health and Demographic Surveillance System (KHDSS)
[18]. One administrative unit in the northern part of the
KHDSS, with a population of predominantly subsistence
farmers, was selected on the basis of ease of road access and the
presence of community health workers assigned to speciﬁc
households facilitating community entry and engagement. In
2009, the estimated total population in the location was 14 998
persons in 1835 homesteads, each comprising a varying
number of households (KHDSS, 2009; unpublished data).
The area has 6 public primary schools and 1 nonboarding sec-
ondary school. Rains occur twice yearly, usually from April to
July and October to December, strongly inﬂuencing migration
patterns for agricultural purposes. RSV epidemics occur annu-
ally. peaking in the ﬁrst quarter of the each year [16].
Study Design
A household-based prospective cohort study was set up with a
recruitment target of 50 RSV naive infants and their household
members. Households (deﬁned in Table 1), identiﬁed through
KHDSS registers and the local community health workers, were
eligible if they included a child born after 1 April 2009, after the
end of the 2008–2009 RSV epidemic, and ≥1 older sibling <13
years of age. Enrollment was undertaken before the anticipated
start of the 2009–2010 RSV season, and sampling visits were
timed to begin and end coincident with the start and ﬁnish of
the expected RSV season [16]. Households were not enrolled if
≥1 individual refused to participate. Trained ﬁeld assistants
made household visits, collecting deep nasopharyngeal swab
(NPS) samples and clinical illness data from all occupants.
Community sensitization and identiﬁcation and recruitment of
study households spanned 1 month, followed by a 4-week
phase of weekly household visits to collect specimens, thereaf-
ter increased to visits every 3–4 days. Households lost to
follow-up during the initial phase were replaced. Individuals
born into households during the course of the study were re-
cruited. NPS samples were also collected once a week from all
ﬁeld team members.
Specimen Collection and Handling
The NPS samples were collected using Copan nasopharyngeal
ﬂocked swabs (catalog No. 503CS01), following the procedure
described elsewhere [19, 20]. On collection, the samples were
stored in a cool box with ice packs, delivered to the study clinic
for temporary storage at approximately 8°C until transported to
KEMRI–Wellcome Trust Research Programme laboratories
within 24 hours for processing, and stored frozen at −70°C.
Laboratory Methods
Viral RNA was extracted from NPS samples using a MagNA
Pure LC RNA Isolation Kit—High Performance (Roche Diag-
nostics) with the MagNA Pure LC Instrument, according to the
manufacturer’s instructions. Testing for RSV was then per-
formed using an in-house real-time multiplex polymerase
chain reaction (PCR) assay [21]. PCR-positive samples were
deﬁned as those with a cycle threshold of ≤35. The long ectodo-
main region of the RSV attachment (G) gene was sequenced as
described elsewhere [22].
Table 1. Deﬁnition of Terms
Term Definitions
Household A group of individuals living in the same
compound and eating food from the same
kitchen
Study infant The youngest child in the household at the time
of recruitment, born after 1 April 2009
RSV season Periods delimited by weeks in which ≥1 RSV
case was identified in hospital surveillance and
≥3 RSV cases were found in any contiguous 3-
wk period [16]
Individual
episode
Period within which an individual provides
specimens that are PCR positive for the same
infecting RSV group with ≤14 d separating any
2 positive samples; if an individual had both
RSVA and B identified in the first sample of
the individual episode, this was coded as a
coinfection and counted as 1 individual
episode
Household
episode
Period within which ≥1 individual episode
occurred in members of the same household
with no ≥14-d interval without a positive
specimen in the household.
Primary case First individual episode in a household based on
sample collection dates; if individual episodes
started on the same date in ≥2 members of
the same household, they were considered
coprimary
Household
outbreak
Occurrence of >1 individual episode within a
household episode (ie, primary infection
spreading to ≥1 other household member)
Visit Instance in which field staff formally met study
participants, at home or at the study clinic,
verified by completion of home or clinic visit
form; this also includes records of missed
appointments (eg, when participants were
away from home)
Abbreviations: PCR, polymerase chain reaction; RSV, respiratory syncytial virus.
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Phylogenetic Analysis
The RSV G gene sequences were aligned using the Bioedit
program (http://www.mbio.ncsu.edu/bioedit/bioedit), with align-
ment of RSV groups A and B separately. Comparison of the
primary-infant case pairs involved regions 648 and 732 nucleo-
tides long for RSV groups A and B, respectively. Only 1 RSV-
positive specimen (with the lowest cycle threshold values) was
selected from each pair for sequencing. Phylogenetic trees were
constructed using MEGA 5 software [23] with maximum likeli-
hood methods, and branch support was assessed by using 1000
bootstrap iterations. Random sequences (10 for each RSV group,
collected from children admitted at the Kiliﬁ District Hospital
during a similar period) were included in the trees as references.
Statistical Analysis
The data were double entered on a custom-made database in
Filemaker Pro software (version 9; Filemaker) and analyzed
using Stata software (version 11.2; StataCorp). Student t, Wil-
coxon rank sum, χ2, and Fisher exact tests were used as appro-
priate. The set of terms and their deﬁnitions used in the data
analysis are given in Table 1. Characteristics were compared
between households with or without infant infections. Infected
individuals were categorized as study infants (referred to here-
after as infants), older children (siblings or cousins aged <15
years), mothers, fathers, or other adults (including aunts,
uncles, grandparents, and cousins aged ≥15 years) in the
household. Infant infections were categorized as originating
from outside the household when the infant was the only
primary case patient or the ﬁrst individual identiﬁed as RSV
positive in a household outbreak and from within the house-
hold if another individual was the ﬁrst in the household identi-
ﬁed as RSV positive. The origin was deemed inconclusive when
the infant and another household member were concurrently
ﬁrst to be identiﬁed as RSV positive (ie, coprimary) in a house-
hold outbreak. For within-household spread and coprimary
cases, RSV attachment (G) gene nucleotide sequences were
compared for the primary case(s) and infant infections.
Ethical Clearance
The study was approved by the Kenyan National Ethical
Review Committee and the University of Warwick’s Biomedical
Research Ethical Committee in the United Kingdom. Individu-
al written informed consent was obtained from all study partic-
ipants aged ≥18 years. For those <18 years old, written consent
was obtained from the parent or guardian.
RESULTS
Households Recruited
Household recruitment started on 4 November 2009 and
reached 50 by 8 December 2009, when regular specimen sam-
pling began. Nine households withdrew during this period,
with 2 replacements. The study was fully in operation, includ-
ing sampling every 3–4 days, by 11 January 2010, the ofﬁcial
study start date. Subsequently, another 4 households were lost
to follow-up, and 8 replacement households were recruited,
with the last recruitment taking place on 5 March and the last
withdrawal on 7 March 2010. The study closed on 4 June 2010,
after 24 weeks of follow-up, Figure 1. Overall, 60 households
(596 participants) were recruited, and 13 households (103 par-
ticipants) were lost to follow-up. Of those lost to follow-up, 6
households were never sampled (3 declined the initial sam-
pling, 2 became ineligible because the parents separated, and 1
became ineligible because of migration); 6 households with-
drew in the course of the study, with the members citing dislike
or fear of the frequent nasopharyngeal swabbing; and 1 house-
hold out-migrated after sampling started. In addition, 3 house-
holds were excluded from this analysis because the study infant
was infrequently sampled during the peak months of RSV in-
fection. All subsequent analyses thus include data from 44
households.
Household characteristics are summarized in Table 2. All
study infants were born after 1 April 2009, with a median age at
recruitment of 4.4 months (interquartile range, 2.4–6.6 months;
range, 13 days to 9.9 months). Twenty-one infants (47.7%)
were male.
Household Visits and Sample Collections
Based on our sampling regimen, a total of 17 985 collected NPS
samples were expected during the study phase. In practice, we
contacted 16 434 participants (91.4%), obtaining 15 396 NPS
samples (85.6% of expected). The proportion of expected NPS
samples collected was highest in study infants (approximately
100%) and lowest among other adults in households (64.3%;
Figure 1. Number of households participating and individual episodes
of respiratory syncytial virus (RSV) A and B infection detected during the
follow-up period (weekly delimited data) in 2009–2010.
Source of RSV Infection in Infants • JID 2014:209 (1 June) • 1687
Table 3). A median of 39 NPS samples were collected per indi-
vidual (interquartile range, 30–42 samples).
RSV Infections in Households
Overall, 84.1% of households (37 of 44) and 38.4% of individual
participants (173 of 451) had ≥1 episode of RSV infection.
A total of 73 separate introductions into households were iden-
tiﬁed, with 32 (43.8%) resulting in a household outbreak.
The 32 outbreaks were identiﬁed in 27 households: 1 outbreak
in 23 households (8 with RSV group A, 14 with RSV group B,
and 2 with a coinfection of both) and 2 outbreaks in 4 house-
holds (2 with RSV group A followed by group B infection and 2
with consecutive group B infections). The study infant was
infected in 28 (87.5%) of the household outbreaks. Households
with RSV spread among the members had a higher mean
number of older children than those without RSV infection,
although the difference was not statistically signiﬁcant (mean,
6.0 [95% conﬁdence interval, 4.4–7.6] vs 3.3 [1.8–4.8]; P = .08;
Supplementary Table 1).
Source of the Infant Infections
Of the 73 separate household episodes identiﬁed, 37 (50.7%) re-
sulted in the infection of the study infants. Overall, 28 of the 44
study infants (63.6%) were infected: 21 had 1 episode, 5 had 2,
and 2 had 3 episodes. The 28 infant infections that were ﬁrst
episodes were associated with an outbreak in 24 households
(85.7%). Subsequent results for the infant infections are limited
to these ﬁrst episodes. The results for all infant episodes are
shown in Supplementary Figure 1. Based on the temporal
pattern of infections in each household, 15 (53.6%) of the 28
study infant infections were acquired through transmission
within households, and 9 (32.1%) were acquired from outside
the household. The source of infant infections in the remaining
4 households (14.3%) was inconclusive because the household
episodes had a sibling and the infant as coprimary case patients
(Figure 2).
Samples were successfully sequenced for the RSV G gene
region in 10 of 15 primary case patient and study infant pairs,
with all pairs showing complete homology of nucleotide se-
quence (Figure 3). In the remaining 5 pairs in which sequenc-
ing failed, ≥1 sample from each pair had a high cycle threshold
value (>30), a proxy for low virus load, based on the real-time
PCR data. Sequences from the coprimary cases were identical
in 3 of the 4 sibling-infant pairs. The primary case patients for
the 15 study infants who seemed to have acquired the infection
from within the household included 11 older children, 1
mother, 1 father, and 2 other adults.
A similar distribution of primary cases was seen for analysis
of all household episodes and outbreaks (Supplementary
Table 2). Ten of the 11 older children who were primary case
patients were attending school, and 1, an adult (uncle to the
study infant, aged 17 years), was in secondary school. The
mean age at recruitment of these older children was 6.9 years
(range, 2.3–11.5 years). In the 4 households in which siblings
were coprimary case patients with infants, 2 siblings were at-
tending school. There were no signiﬁcant differences in indi-
vidual or household characteristics between infected and
uninfected infants (Table 4). None of the ﬁeld team members
had RSV infection detected during the study period.
DISCUSSION
We report on a study designed to determine the source of RSV
infection in infants during their ﬁrst epidemic, as those who are
most vulnerable to disease from RSV infection. The aim was to
establish the proportion of infants infected from a source
within the immediate household and, in such households, to
determine which member was responsible for introducing RSV
into the household. Data from rural coastal Kenya are
Table 2. Baseline Characteristics of Study Infants and Their
Households
Characteristic Statistic
Study infants (n = 44)
Male sex, No. (%) 21 (47.7)
Age at recruitment, median (IQR), mo 4.2 (2.4–6.4)
Other household members (n = 407)
Male sex, No. (%) 186 (45.7)
In school, No. (%) 154 (37.8)
Age at recruitment, median (IQR), y 12.6 (6.6–26.5)
Frequency distribution of members by age at recruitment, No. (%)
0 to <1 y 6 (1.5)
1–4 y 74 (18.2)
5–14 y 153 (37.6)
15–39 y 133 (32.7)
≥40 y 41 (10.1)
Household members, median (IQR), No.
Total 8 (6–11.5)
Older children (aged 1–14 y) 4 (3–6)
School-going children 4 (3–6)
Members living in same building unit as
study infant
5 (3–6)
Mothers with no formal education, No. (%) 10/43 (23.3)
Duration of household follow-up,
median (IQR), wk
24.8 (23.6–25.3)
Frequency distribution in RSV episodes per household, No. (%)
0 7 (15.9)
1 16 (36.4)
2 11 (25.0)
3 8 (18.2)
≥4 2 (4.5)
Abbreviations: IQR, interquartile range; RSV, respiratory syncytial virus.
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presented for 44 households, with 451 members recruited and
followed up actively for NPS sample collection every 3–4 days
regardless of symptoms during a full RSV epidemic. Sensitive
diagnosis of infection was achieved by using a real-time PCR
assay. Through a lengthy process of community engagement
and trust building, it was possible to achieve high household
retention and sample collection during the 6 months of the
study. RSV infection was detected in 84.1% of the households
and 38.4% of the participants. Both known RSV subtypes (A
and B) circulated in the community during the study period,
which helped distinguish infection episodes and transmission
events.
The study infant was infected at least once in 28 of the 44
households, with about a third (32.1%) acquiring the infection
from outside the household and about half (53.6%) from
within the household. In the remaining (14.3%) households,
the source of infant infection was undetermined because the
infant and sibling were coprimary case patients. Children at-
tending school were important in the within-household trans-
mission, comprising 67% of the total (ie, 10 of 15) and 90% of
the childhood case patients (ie, 10 of 11). Mothers or fathers
were less likely to be the primary case patients. There were no
statistically signiﬁcant differences between the individual or
household characteristics of infected and uninfected infants,
suggesting that differences between households are based
largely on chance or factors not observed in the current study.
In addition, the distribution of the primary cases was similar
for isolated household episodes (ie, episodes with no household
spread) and outbreaks of RSV, indicating that whether or not
the infection spreads is determined not by who brings the in-
fection into the household but maybe by chance or by an unob-
served characteristic of the household, such as whether an
outbreak was experienced in the previous year(s).
Only 1 study in the past has looked at the spread of RSV
within households in detail [24]. Hall and colleagues recruited
36 US families with young infants, collecting nose or throat
Figure 2. Distribution of primary cases for the 28 household episodes
linked with the study infant infection in rural Kenya. Only the ﬁrst
household episodes/outbreaks involving the study infants are shown. The
diagonal and zigzag lines shading the circles indicate outside- and within-
household acquisition of the infant infections, respectively, and the area
of the circle is in proportion to the number of cases in each category.
Table 3. Visits and NPS Sample Collections From 451 Participants During Study Phase, Stratiﬁed by Relation of Individuals to Study
Infant
Study Participantsa
Individual Visits, No. (%)
Clinic Visits,
No.
NPS Sample Collections, No. (%)
Allb At Home Away Expectedc Collectedd When Symptomatice
Study infants (n = 44) 1846 1764 (95.6) 82 (4.4) 92 1752 1763 (100.6) 912 (52.1)
Siblings (n = 157) 6453 6109 (94.7) 344 (5.3) 81 6224 5871 (94.3) 1710 (27.5)
Cousins (n = 105) 4197 3662 (87.3) 535 (12.7) 58 4202 3378 (80.4) 749 (17.8)
Mothers (n = 43) 1792 1708 (95.3) 84 (4.7) 45 1716 1695 (98.8) 162 (9.4)
Fathers (n = 31) 1239 1024 (82.6) 215 (17.4) 7 1224 845 (69.0) 51 (4.2)
Other adults (n = 71) 2741 2167 (79.1) 574 (20.9) 45 2867 1844 (64.3) 178 (6.2)
Overall (n = 451) 18 268 16 434 (90.0) 1834 (10.0) 328 17 985 15 396 (85.6) 3762 (20.9)
Abbreviations: NPS, nasopharyngeal swab.
a Household members stratified by relation to study infant.
b Includes all instances in which field workers formally visited study participants at home, verified by completion of the home visit form and including records of
when the participant was away from home.
c Total number of NPS sample collections expected if samples were collected twice a week, discounting periods when household members were reported to be
away from the household for >3 consecutive days.
d Additional samples were collected during clinic visits when participants were symptomatic.
e NPS samples collected when participant had symptoms of acute respiratory illness defined by presence of ≥1 of the following symptoms: cough, blocked nose/
nasal discharge, or difficult in breathing.
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samples twice a week regardless of symptoms during 2 months
of an RSV season and assessing infection using viral culture
[24]. RSV was detected in 16 (44.4%) of the families and 21.9%
of the 188 members, lower rates than in the current study
(84.1% and 38.4%, respectively). Based only on temporal occur-
rence of infections, RSV seemed to be introduced by siblings in
8 (50.0%) of 16 infected families; by other household members,
including parents, in 3 families (18.8%); and with involvement
of an infant in 5 (31.3%; coprimary cases). The corresponding
statistics for the 32 household outbreaks recorded in our study
were 16 (50.0%), 5 (15.6%), and 11 (34.4%). As in our study,
these ﬁndings highlight the importance of older children in in-
troducing RSV into households with young infants. Our study
also shows that children with daily contact with many other
children, particularly in schools, are important in bringing RSV
infections into the households.
Other, less comparable studies have implicated siblings [25–
29] and mothers [30] as source of infections in the family for
Figure 3. A, Temporal occurrence of respiratory syncytial virus (RSV)–positive samples in a household of 5 members (household 40). Each box represent
a sample collected; each circle, an RSV-positive sample. RSV was introduced by subject 4004. B, An Maximum Likelihood phylogenetic tree of 10 of 12
samples from household 40 together with 10 RSVA reference sequences from Kiliﬁ District Hospital (KDH). All samples from household 40 (preceded by
triangles on tree) had identical sequences in the G region sequenced. C, Phylogenetic relationship of the G similarity of study infant–primary case pairs for
RSVA. Samples from the same household are preceded by the same symbol (ﬁlled or open). Taxon naming for the household samples follows household
number with individual number and date of sampling (eg, 4703_02April2010 represents household 47, individual 3, and sample collected on 2 April 2010).
The KDH RSVA reference sequences are as in B. D, Same as C, but for RSV B. An example RSV B pairing is 3803_14Feb2010 and the later infant-infecting
virus sequence 3801_27Feb2010. Ten random samples from the KDH inpatient studies are included for reference, as in B and C.
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young infants. However, none of these studies [25–30] were de-
signed speciﬁcally to identify the source of infant RSV infections
in families. Our current study and the family study by Hall et al
in Rochester, New York [24] were designed to identify trans-
mission chains by sampling frequently and irrespective of symp-
toms. However, because methods have changed since the US
study [24], our study has the advantages of increased sensitivity
in case detection with PCR and of sequence data support for
observed primary-infant infection pairs. Moreover, the US
study is likely to have missed infections early in the RSV epi-
demic owing to sampling delay and suffered a high proportion
of coprimary cases, restricting the ability to identify relative in-
dividual contributions as infection sources within families.
Nevertheless, the consistency of results, given the contrasting
locations and different times, suggest that the important role of
a school-age sibling in bringing infection into the household is
not unique to a particular social and demographic setting.
Our results support the notion that preventing infection in
school-going children could indirectly reduce RSV infection in
infants. However, an assessment of the impact of such an inter-
vention requires consideration of the competing risks; for
example, somebody other than the vaccinated child might in-
troduce infection or the infant might be infected in the com-
munity if not the household. However, targeted sibling
immunization would nonetheless result in fewer susceptible in-
dividuals within the household, which would reduce spread
and provide indirect infant protection, and any reduction in
rate of infection to infants will translate into a delay in infection
to an older age, reducing the risk of disease.
These results also point to schoolchildren as the “core
group” for RSV. Consequently, universal immunization of chil-
dren (regardless of sibling status) could reduce circulation of
RSV in the community, especially in typical rural African com-
munities with many children like the one we studied, further
reducing the risk of infant infection. However, such an inter-
vention is more likely to interrupt the transmission dynamics
of RSV and may change the seasonality and the age distribution
of susceptibility and infection. We are currently conducting
modeling studies to address these issues by further clarifying
the details of transmission within the household and the
impact of mass immunization.
The current study also has some limitations. First, generaliz-
ability of the results is limited in that we speciﬁcally selected
households with an older child, and the households were few
and within a tight geographic area populated by rural farmers.
It would be important to identify the source of infant infections
in households without older children. However, only 19.6% of
the infants in the KHDSS live in households without an older
child in their compound. Second, the frequency of sampling
might have missed short-duration RSV shedding (if <3 days),
including primary cases, despite the intensive sampling. For
some instances in which the infant is the primary or coprimary
case patient, the index case patient may have gone unidentiﬁed.
This risk is larger than the alternative (wherein the infant was
actually the ﬁrst case patient but not identiﬁed as such by us),
because sample collection in infants was thorough and infants
were mainly infected in the ﬁrst few days after infection was in-
troduced into household (Supplementary Figure 1 in the Sup-
plementary material). We therefore believe that our estimate of
the importance of within-household spread as a source of
infant infections is an underestimate. Third, given that it is
more difﬁcult to diagnose RSV in adults than in children [31],
the role of parents or grandparents in household RSV may have
been underestimated. However, the use of sensitive real-time
PCR will have mitigated problem this to a signiﬁcant degree.
The serological identiﬁcation of cases may have reduced mis-
classiﬁcation of infection but would not have helped in the res-
olution of transmission chains. Further work is planned using
full-genome sequencing in positive samples to identify molecu-
lar ﬁngerprints that might help delineate the chains of RSV
spread within households.
In conclusion, we demonstrate that in this rural Kenyan loca-
tion, for a high proportion of infant RSV infections, the source
is from the household and predominantly introduced by an
elder school-going sibling. Thus, there is potential for targeted
immunization of older siblings of naive infants, or universal
vaccination of older infants and children, to reduce the spread
of RSV and the risk of infection entering households and to
delay ﬁrst infection in infants to an older age at which associat-
ed disease is less of a risk.
Table 4. Characteristics of Households With or Without Respira-
tory Syncytial Virus Infections in Study Infantsa
Household
Characteristic
No Infection in
Infants (n = 16)
Infection in
Infants (n = 28)
P
Value
Household
members, No.
8.0 (7.0–9.0) 9.0 (6.0–14.5) .44
Age of members,
mean (95% CI), y
16.0 (14.2–17.8) 15.8 (14.3–17.2) .77
Age of study
infant, mo
4.3 (3.1–5.5) 4.7 (3.7–5.7) .63
Older children, No. 4.0 (3.0–5.0) 5.0 (3.0–7.5) .23
Male household
members, %
50.0 (40.0–57.1) 41.4 (35.8–57.7) .44
School-going
children, No.
4.0 (2.0–4.0) 4.0 (3.0–7.0) .24
Members living in
same building
unit with study
infant, No.
6.0 (4.5–6.0) 4.5 (3.0–6.5) .23
Abbreviation: CI, confidence interval; RSV, respiratory syncytial virus.
a Data represent medians (interquartile ranges) except where otherwise
indicated.
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Supplementary Data
Supplementary materials are available at The Journal of Infectious Diseases
online (http://jid.oxfordjournals.org/). Supplementary materials consist of
data provided by the author that are published to beneﬁt the reader. The
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